Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Alejandra Zazueta, Lucía Valenzuela-Pérez, Nicolás Ortiz‐López, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4387-4387
Open Access | Times Cited: 10

Showing 10 citing articles:

Exploring Molecular Mechanisms of Liver Fibrosis
Ralf Weiskirchen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 326-326
Open Access
The role of liver sinusoidal endothelial cells in metabolic dysfunction-associated steatotic liver diseases and liver cancer: mechanisms and potential therapies
Hanjun Mo, Pengfei Yue, Qiaoqi Li, et al.
Angiogenesis (2025) Vol. 28, Iss. 2
Closed Access
Clostridioides difficile infection induces a pro-inflammatory and pro-steatotic metabolic state in liver
Farnaz Yousefi, Brett Sponseller, Muhammed Shafeekh Muyyarikkandy, et al.
npj gut and liver. (2025) Vol. 2, Iss. 1
Open Access
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
Farah Abdelhameed, A.I. Mustafa, Chris Kite, et al.
Livers (2025) Vol. 5, Iss. 1, pp. 11-11
Open Access
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women
Ilaria Milani, Marianna Chinucci, Frida Leonetti, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 855-855
Open Access
The Role of Microbiota-Related Co-Metabolites in MASLD Progression: A Narrative Review
María Martín-Grau, Daniel Monleón
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6377-6389
Open Access | Times Cited: 3
Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Sevag Hamamah, Oana C. Iatcu, Mihai Covașă
Nutrients (2024) Vol. 17, Iss. 1, pp. 143-143
Open Access | Times Cited: 2
Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study
Nicolás Ortiz‐López, Ana María Madrid, Larissa Aleman, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Biological aging accelerates hepatic fibrosis: Insights from the NHANES 2017–2020 and genome-wide association study analysis.
J. Zhao, Huiying Zhou, Rui Wu, et al.
Annals of Hepatology (2024) Vol. 30, Iss. 2, pp. 101579-101579
Open Access
Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD)
Irene Mignini, Linda Galasso, Giulia Piccirilli, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1532-1532
Open Access
Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
Liangtao Zhao, Haolan Tang, Zhangjun Cheng
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1724-1724
Open Access
Page 1

Scroll to top